View in EDS HTML Full Text PDF Full Text

Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with recurrent glioblastoma.

Saved in:
Bibliographic Details
Title: Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with recurrent glioblastoma.
Authors: Lu, Yinghao1 (AUTHOR), Liao, Limin1 (AUTHOR), Du, Kunpeng1 (AUTHOR), Mo, Jianhua2 (AUTHOR), Zou, Xia2 (AUTHOR), Liang, Junxian3 (AUTHOR), Chen, Jiahui1 (AUTHOR), Tang, Wenwen1 (AUTHOR), Su, Liwei1 (AUTHOR), Wu, Jieping1 (AUTHOR), Zhang, Junde1 (AUTHOR) 13002087575@163.com, Tan, Yujing1 (AUTHOR) tanyujing-1981@163.com
Source: BMC Cancer. 1/25/2024, Vol. 24 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-024-11848-z